AP
REGN icon

Appleton Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Appleton Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-907
Closed -$797K – 283
2023
Q4 		$797K Hold
907
– – 0.06% 152
2023
Q3 		$746K Sell
907
-3
-0.3% -$2.36K 0.07% 153
2023
Q2 		$654K Hold
910
– – 0.06% 174
2023
Q1 		$748K Hold
910
– – 0.07% 175
2022
Q4 		$657K Hold
910
– – 0.06% 179
2022
Q3 		$627K Hold
910
– – 0.06% 183
2022
Q2 		$538K Sell
910
-8
-0.9% -$5.2K 0.05% 194
2022
Q1 		$641K Sell
918
-3
-0.3% -$1.9K 0.05% 190
2021
Q4 		$582K Buy
+921
New +$566K 0.04% 208

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return